7 hours Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Helen Torley Sells 10,000 Shares MarketBeat
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) CEO Helen Torley sold 10,000 shares of the stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of $56.34, for a total value of $563,400….